211
Views
19
CrossRef citations to date
0
Altmetric
Review

New formulations of drugs in epilepsy

&
Pages 49-60 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paul H McCabe. (2000) New anti-epileptic drugs for the 21st century. Expert Opinion on Pharmacotherapy 1:4, pages 633-674.
Read now

Articles from other publishers (18)

Jeremy Jost, Pierre-Marie Preux, Michel Druet-Cabanac & Voa Ratsimbazafy. (2016) How to reduce the treatment gap for people with epilepsy in resource-limited settings by innovative galenic formulations: A review of the current situation, overview of potential techniques, interests and limits. Epilepsy Research 119, pages 49-61.
Crossref
Wilma S. W. Wichards, Alfred F. A. M. Schobben & Frans S. S. Leijten. (2013) Perioperative substitution of anti-epileptic drugs. Journal of Neurology 260:11, pages 2865-2875.
Crossref
Nathan B. Fountain, Gregory Krauss, Jouko Isojarvi, Deanne Dilley, Pamela Doty & G. David Rudd. (2012) Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide‐naive patients with partial‐onset seizures. Epilepsia 54:1, pages 58-65.
Crossref
Benjamin Legros, Paul Boon, Berten Ceulemans, Thomas Coppens, Karine Geens, Henri Hauman, Lieven Lagae, Alfred Meurs, Leon Mol, Michel Ossemann, Kenou van Rijckevorsel, Michel Van Zandijcke, Pascal Vrielynck, Daniëlla Wagemans & Thierry Grisar. (2012) Development of an electronic decision tool to support appropriate treatment choice in adult patients with epilepsy – Epi-Scope®. Seizure 21:1, pages 32-39.
Crossref
Vijay Ivaturi & James Cloyd. 2010. Epilepsy. Epilepsy 553 571 .
Gregory Krauss, Elinor Ben‐Menachem, Ruta Mameniskiene, Nerija Vaiciene‐Magistris, Melissa Brock, John G. Whitesides & Martin E. Johnson. (2010) Intravenous lacosamide as short‐term replacement for oral lacosamide in partial‐onset seizures. Epilepsia 51:6, pages 951-957.
Crossref
Victor Biton, William E. Rosenfeld, John Whitesides, Nathan B. Fountain, Nerija Vaiciene & G. David Rudd. (2008) Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49:3, pages 418-424.
Crossref
J. G. Burneo & R. S. McLachlan. (2014) Treating Newly Diagnosed Epilepsy: The Canadian Choice. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 34:2, pages 230-236.
Crossref
Meir Bialer. (2007) Extended-Release Formulations for the Treatment of Epilepsy. CNS Drugs 21:9, pages 765-774.
Crossref
Steven Karceski, Martha J. Morrell & Daniel Carpenter. (2005) Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy & Behavior 7, pages 1-64.
Crossref
Kian-Ti Yu. 2005. Pediatrics. Pediatrics 275 278 .
Michael C. Smith, Franca Centorrino, Jeffrey A. Welge & Michelle A. Collins. (2004) Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials. Epilepsy & Behavior 5:5, pages 746-751.
Crossref
John M Pellock. (2004) Safety of Diastat??, a Rectal Gel Formulation of Diazepam for Acute Seizure Treatment. Drug Safety 27:6, pages 383-392.
Crossref
Luiz Eduardo Betting, Eliane Kobayashi, Maria Augusta Montenegro, Li Li Min, Fernando Cendes, Marilisa M. Guerreiro & Carlos A.M. Guerreiro. (2003) Tratamento de epilepsia: consenso dos especialistas brasileiros. Arquivos de Neuro-Psiquiatria 61:4, pages 1045-1070.
Crossref
Robert S. Fisher & Jet Ho. (2002) Potential New Methods for Antiepileptic Drug Delivery. CNS Drugs 16:9, pages 579-593.
Crossref
Bernard Masereel, Stéphanie Rolin, Francesco Abbate, Andrea Scozzafava & Claudiu T. Supuran. (2001) Carbonic Anhydrase Inhibitors:  Anticonvulsant Sulfonamides Incorporating Valproyl and Other Lipophilic Moieties. Journal of Medicinal Chemistry 45:2, pages 312-320.
Crossref
Steven Karceski, Martha Morrell & Daniel Carpenter. (2001) The Expert Consensus Guideline Series. Epilepsy & Behavior 2:6, pages A1-A50.
Crossref
Katherine D. Holland. (2001) Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Neurologic Clinics 19:2, pages 313-345.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.